CVE-2023-6260

Web UI OS Command Injection in Brivo ACS100, ACS300

Description

Improper Neutralization of Special Elements used in an OS Command ('OS Command Injection') vulnerability in Brivo ACS100, ACS300 allows OS Command Injection, Bypassing Physical Security.This issue affects ACS100 (Network Adjacent Access), ACS300 (Physical Access): from 5.2.4 before 6.2.4.3.

Category

9.0
CVSS
Severity: Critical
CVSS 3.1 •
EPSS 0.08%
Third-Party Advisory sra.io
Affected: Brivo ACS100, ACS300
Published at:
Updated at:

References

Link Tags
https://sra.io/advisories/ third party advisory
https://support.brivo.com/l/en/article/g82txdwepa-brivo-firmware-release-notes#brivo_firmware_release_6_2_4_3 release notes

Frequently Asked Questions

What is the severity of CVE-2023-6260?
CVE-2023-6260 has been scored as a critical severity vulnerability.
How to fix CVE-2023-6260?
To fix CVE-2023-6260, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-6260 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-6260 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-6260?
CVE-2023-6260 affects Brivo ACS100, ACS300.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.